Evaluation for NCI Surgery Branch Clinical Research Protocols
Recruiting
7,000 enrolled
MK-3475-G21
Phase 1/2 Recruiting
20 enrolled
ACTengine
Phase 1/2 Recruiting
375 enrolled
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Phase 1 Recruiting
124 enrolled
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Phase 2 Recruiting
87 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
Project: Every Child for Younger Patients With Cancer
Recruiting
75,000 enrolled
ARTACUS
Phase 1/2 Recruiting
90 enrolled
The Florida ASCENT Study
Phase NA Recruiting
100 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
SELECT-CAR-NK
Phase 1/2 Recruiting
85 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
270 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
ON-5001
Phase 1 Recruiting
168 enrolled
A Study of DEG6498 in Participants With Solid Tumors
Phase 1 Recruiting
100 enrolled
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Phase 1 Recruiting
56 enrolled
Study of GV20-0251 in Participants With Solid Tumor Malignancies
Phase 1/2 Recruiting
350 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
LIBERATE
Recruiting
2,500 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Phase 2 Recruiting
100 enrolled
NST-628
Phase 1 Recruiting
230 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
AGADIR
Phase 2 Recruiting
247 enrolled
A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
Phase 1 Recruiting
66 enrolled
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Phase 1 Recruiting
45 enrolled
Observational Study of Iris Tumors
Recruiting
100 enrolled
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
Recruiting
350 enrolled
CR3C
Recruiting
300 enrolled
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
Phase 1 Recruiting
50 enrolled
DP-PAN-CANCER
Phase NA Recruiting
450 enrolled
In Vivo Real-time Detection of Circulating Melanoma Cells
Recruiting
75 enrolled
ABILITY-1
Phase 1/2 Recruiting
115 enrolled
START-001
Phase 1/2 Recruiting
365 enrolled
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Recruiting
240 enrolled
Adaptive Symptom Self-Management Immunotherapy Study
Phase NA Recruiting
400 enrolled
LONGEVITI
Recruiting
75 enrolled
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Phase NA Recruiting
2,996 enrolled
PRIME
Phase 3 Recruiting
1,204 enrolled
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Phase 1/2 Recruiting
365 enrolled
GENIUS
Recruiting
100 enrolled
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Phase 1/2 Recruiting
168 enrolled
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Phase 1/2 Recruiting
53 enrolled
MelMarT-II
Phase NA Recruiting
2,998 enrolled
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Phase 1/2 Recruiting
316 enrolled